Evidence map›Paper›PMID 31860172›Full record

ArticleJournal of the International AIDS Society2019

Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.

Adam W Carrico, Torsten B Neilands, Samantha E Dilworth, Jennifer L Evans, Walter Gόmez, Jennifer P Jain, Monica Gandhi, Steven Shoptaw, Keith J Horvath, Lara Coffin and 5 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 54 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 7 pooled it
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05929040 nacompletednot on this mapstarted 2022, after this paper: background citation

Using the Behaviour Change Technique Taxonomy v1 to Conceptualize the Clinical Content of a Preliminary Randomised Controlled Study of an Online Mindfulness-based Cognitive Intervention for Chemsex

TypeinterventionalSponsorLondon Metropolitan UniversityRan2022 to 2023Enrolled29ConditionsSubstance UseArmsmindful cognitive intervention
NCT07281378 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.

TypeinterventionalSponsorUniversity of FloridaRan2026 to 2027Enrolled84ConditionsDrug Use Disorders, PrEP Uptake, PrEP Adherence, HIV Risk BehaviorArmsTailored Positive Affect Intervention, Contingency Management
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 7 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Psychosocial interventions for stimulant use disorder.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Pooled it
  5. Posttraumatic growth and well-being among people living with HIV: A systematic review and meta-analysis in recognition of 40 years of HIV/AIDS.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Adam W CarricoUniversity of Miami School of Medicine, Miami, FL, USA.ORCID 0000-0002-8146-5701
Torsten B NeilandsSan Francisco School of Medicine, University of California, San Francisco, CA, USA.ORCID 0000-0001-7936-9123
Samantha E DilworthSan Francisco School of Medicine, University of California, San Francisco, CA, USA.
Jennifer L EvansSan Francisco School of Medicine, University of California, San Francisco, CA, USA.
Walter GόmezBerkeley School of Social Welfare, University of California, Berkeley, CA, USA.
Jennifer P JainSan Diego School of Medicine, University of California, La Jolla, CA, USA.ORCID 0000-0002-6339-1649
Monica GandhiSan Francisco School of Medicine, University of California, San Francisco, CA, USA.
Steven ShoptawDepartments of Family Medicine and Psychiatry, Los Angeles David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID 0000-0002-3583-0026
Keith J HorvathDepartment of Psychology, San Diego State University, San Diego, CA, USA.
Lara CoffinSan Francisco School of Medicine, University of California, San Francisco, CA, USA.
Michael V DiscepolaSan Francisco AIDS Foundation, San Francisco, CA, USA.
Rick AndrewsSan Francisco AIDS Foundation, San Francisco, CA, USA.
William J WoodsSan Francisco School of Medicine, University of California, San Francisco, CA, USA.
Daniel J FeasterUniversity of Miami School of Medicine, Miami, FL, USA.ORCID 0000-0002-6172-7460
Judith T MoskowitzDepartment of Medical Social Sciences, Northwestern University, Chicago, CA, USA.ORCID 0000-0002-1399-3318
University of California, San Francisco · USSan Francisco AIDS Foundation · USUniversity of Miami · USNorthwestern University · USSan Diego State University · USUniversity of California, Berkeley · USUniversity of California, Los Angeles · USUniversity of California San Diego · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention TrialsR01AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GANDHI, MONICA · 2012 to 2021
$5.6M
“Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.R37AI098472 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2023 to 2026
$3.2M
RCT of an integrative intervention for non-treatment-seeking meth usersR01DA033854 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARRICO, ADAM WAYNE, MOSKOWITZ, JUDITH T. · 2013 to 2017
$2.8M
Positive Affect Regulation for HIV Prevention in People with Mood DisordersK24MH093225 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOSKOWITZ, JUDITH T. · 2011 to 2015
$713k
NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI098472NIAID NIH HHS R37 AI098472NIDA NIH HHS R01 DA033854NIDA NIH HHS T32 DA023356NIMH NIH HHS K24 MH093225NIMH NIH HHS P30 MH058107NIMH NIH HHS P30 MH062246NIMH NIH HHS P30 MH116867
6 · The paper itself

Abstract

introductionIn the era of HIV treatment as prevention (TasP), evidence-based interventions that optimize viral suppression among people who use stimulants such as methamphetamine are needed to improve health outcomes and reduce onward transmission risk. We tested the efficacy of positive affect intervention delivered during community-based contingency management (CM) for reducing viral load in sexual minority men living with HIV who use methamphetamine.

methodsConducted in San Francisco, this Phase II randomized controlled trial tested the efficacy of a positive affect intervention for boosting and extending the effectiveness of community-based CM for stimulant abstinence to achieve more durable reductions in HIV viral load. From 2013 to 2017, 110 sexual minority men living with HIV who had biologically confirmed, recent methamphetamine use were randomized to receive a positive affect intervention (n = 55) or attention-control condition (n = 55). All individual positive affect intervention and attention-control sessions were delivered during three months of community-based CM where participants received financial incentives for stimulant abstinence. The 5-session positive affect intervention was designed to provide skills for managing stimulant withdrawal symptoms as well as sensitize individuals to natural sources of reward. The attention-control condition consisted of neutral writing exercises and self-report measures.

resultsMen randomized to the positive affect intervention displayed significantly lower log

conclusionsDelivering a positive affect intervention during community-based CM with sexual minority men who use methamphetamine achieved durable and clinically meaningful reductions in HIV viral load that were paralleled by increases in positive affect and decreases in stimulant use. Further clinical research is needed to determine the effectiveness of integrative, behavioural interventions for optimizing the clinical and public health benefits of TasP in sexual minority men who use stimulants such as methamphetamine.

Indexed as

Amphetamine-Related DisordersBehavior TherapyHomosexuality, MaleMethamphetamineAdultFemaleHIV InfectionsHumansMaleMiddle AgedSerologic TestsViral LoadMethamphetaminecontingency managementHIVmen who have sex with menmethamphetaminemindfulnesspositive affect

Identifiers

PMID31860172
PMCPMC6924317
OpenAlexW2996618907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.